Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models

SARS-CoV-2 is the coronavirus that causes the respiratory disease COVID-19, which is now the third-leading cause of death in the United States. The FDA has recently approved remdesivir, an inhibitor of SARS-CoV-2 replication, to treat COVID-19, though recent data from the WHO shows little to no bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoquan, Lidsky, Peter, Xiao, Yinghong, Wu, Chien-Ting, GarciaKnight, Miguel, Yang, Junjiao, Nakayama, Tsuguhisa, Nayak, Jayakar V., Jackson, Peter K., Andino, Raul, Shu, Xiaokun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605555/
https://www.ncbi.nlm.nih.gov/pubmed/33140048
http://dx.doi.org/10.1101/2020.10.28.359042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605555/
https://www.ncbi.nlm.nih.gov/pubmed/33140048
http://dx.doi.org/10.1101/2020.10.28.359042

Ejemplares similares